A detailed history of Aqr Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 1,711,734 shares of ABBV stock, worth $290 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,711,734
Previous 1,404,428 21.88%
Holding current value
$290 Million
Previous $241 Million 40.33%
% of portfolio
0.47%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $50.3 Million - $61.3 Million
307,306 Added 21.88%
1,711,734 $338 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $20.8 Million - $24.2 Million
-134,055 Reduced 8.71%
1,404,428 $241 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $49 Million - $55.8 Million
-306,614 Reduced 16.62%
1,538,483 $280 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $47.9 Million - $53.9 Million
348,011 Added 23.25%
1,845,097 $286 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $44.3 Million - $51.3 Million
331,662 Added 28.46%
1,497,086 $223 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $3.82 Million - $4.75 Million
-28,800 Reduced 2.41%
1,165,424 $157 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $32.9 Million - $37.9 Million
-227,583 Reduced 16.01%
1,194,224 $190 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $5 Million - $5.99 Million
-36,141 Reduced 2.48%
1,421,807 $230 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $28 Million - $32.1 Million
-208,400 Reduced 12.51%
1,457,948 $196 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $18.1 Million - $23 Million
-131,592 Reduced 7.32%
1,666,348 $253 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $30.7 Million - $38 Million
-232,348 Reduced 11.44%
1,797,940 $291 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $6.21 Million - $7.86 Million
57,832 Added 2.93%
2,030,288 $275 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $11 Million - $12.5 Million
103,628 Added 5.55%
1,972,456 $213 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $40.8 Million - $45.4 Million
-387,539 Reduced 17.18%
1,868,828 $209 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $21 Million - $23.1 Million
-205,311 Reduced 8.34%
2,256,367 $243 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $97.4 Million - $132 Million
-1,210,419 Reduced 32.96%
2,461,678 $260 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $142 Million - $167 Million
-1,653,574 Reduced 31.05%
3,672,097 $319 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $169 Million - $225 Million
2,296,582 Added 75.82%
5,325,671 $512 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $81.1 Million - $123 Million
1,257,587 Added 70.99%
3,029,089 $231 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $45 Million - $56.3 Million
623,364 Added 54.29%
1,771,502 $157 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $113 Million - $135 Million
-1,789,134 Reduced 60.91%
1,148,138 $86.5 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $134 Million - $171 Million
-2,039,418 Reduced 40.98%
2,937,272 $212 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $73.3 Million - $86.3 Million
950,737 Added 23.62%
4,976,690 $400 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $75.3 Million - $92.9 Million
-967,494 Reduced 19.38%
4,025,953 $371 Million
Q3 2018

Nov 15, 2018

BUY
$88.91 - $98.84 $82.8 Million - $92.1 Million
931,390 Added 22.93%
4,993,447 $472 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $84.3 Million - $99.7 Million
-938,798 Reduced 18.77%
4,062,057 $380 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $46.7 Million - $62.6 Million
507,695 Added 11.3%
5,000,855 $473 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $67.4 Million - $73.9 Million
752,859 Added 20.13%
4,493,160 $435 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $261 Million - $334 Million
3,740,301
3,740,301 $332 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.